Risedronate sodium 2.5-hydrate

Inquiry

Please complete the form below and we will contact you as soon as possible.

First Name*

Last Name

E-mail*

Phone

Country

Company*

Message

Check All

I agree to the Privacy Policy*I consent to the processing of my personal data in the form of first name, last name, e-mail address, company name, and job title by Zakłady Farmaceutyczne "Polpharma" S.A. based in Starogard Gdański (postal code: 83-200), ul. Pelplińska 19, for marketing purposes. I am aware that my consent may be withdrawn at any time.I consent to the processing of my personal data in the form of first name, last name, e-mail address, company name, and job title by Zakłady Farmaceutyczne "Polpharma" S.A. based in Starogard Gdański (postal code: 83-200), ul. Pelplińska 19, for the purpose of profiling and providing me with dedicated/tailored materials - including advertising materials based on the analysis of processed personal data. I am aware that my consent may be withdrawn at any time.I consent to receiving from Polpharma API, brand of Zakłady Farmaceutyczne "Polpharma" S.A. based in Starogard Gdański (postal code: 83-200), ul. Pelplińska 19, by means of electronic communication through the e-mail channel, commercial information within the meaning of the Act of 18 July, 2002 on Providing Services by Electronic Means (Journal of Laws 2002, No. 144, item 1204, as amended).

* - mandatory field

Send

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Technical details

Risedronate sodium 2.5-hydrate

API is an active pharmaceutical ingredient in the

Musculo-skeletal system

therapeutic category, manufactured by Polpharma API CDMO in Europe. CAS number:

329003-65-8

Development status:

Commercial

CAS:

329003-65-8

Status:

Commercial

Therapeutic cat.

Musculo-skeletal system

Injectable forms:

Injectable

Polymorphic form:

Form A

Documentation:

Brazilian DMF

CEP

Canadian DMF

EU DMF

Japanese DMF

Korean DMF